Wednesday, September 09

Top Stories

August 25, 2025

HZL eyes rare earths, seeks global collab

Vedanta group firm Hindustan Zinc Ltd is actively exploring opportunities in rare earth elements and seeking global partners for AI and drone-based exploration of critical minerals, Chairperson Priya Agarwal Hebbar on Monday said. Addressing the shareholders during the 59th Annual General Meeting, Hebbar said, "Further, we are actively pursuing exploration opportunities in copper, lithium, nickel, cobalt, potash, and rare earth elements, while also looking at neodymium from monazite, antimony, graphite, and germanium." Rare earth elements are essential to modern technology. From smartphones and electric vehicles to wind turbines, defence systems, and advanced electronics, these minerals are the backbone of both civilian and military-industrial capabilities. "We have already floated intern

August 25, 2025

Vodafone Idea shares rally over 10% in 2 days amid AGR relief buzz

Shares of Vodafone Idea extended their rebound on Monday, rising as much as 2.3% to Rs 7.23 on BSE after an 8% surge on Friday. The two-day rally of 10.2% follows reports that the Prime Minister’s Office is reviewing a relief package for the debt-laden telecom operator, rekindling hopes of support on its massive adjusted gross revenue (AGR) dues.On Friday, Vodafone Idea shares jumped 9.3% intraday to Rs 7.17 before closing 7.8% higher at Rs 7.07, after reports that the Department of Telecommunications had informally shared proposed bailout measures with the PMO. These include a two-year extension of the moratorium on statutory dues, more repayment flexibility, reduced annual installments, and possible waivers on penalties and interest, according to Moneycontrol.Vodafone Idea owes about R

August 25, 2025

Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation

Shares of Cohance Lifesciences surged 5.5% to Rs 935 in intraday trade after Jefferies initiated coverage with a ‘Buy’ rating and a target price of Rs 1,150. The global brokerage expressed a bullish outlook on select Indian pharma and CRDMO companies, assigning ‘Buy’ ratings to Cohance Lifesciences, Divi’s Laboratories, and SAI Life Sciences, with an estimated upside potential of up to 30%.The news triggered an upward rally in the stocks, with Cohance Lifesciences gaining 5.5%, Divi’s Laboratories advancing 2.5% to an intraday high of Rs 6,314.5, and SAI Life Sciences rising about 2% to Rs 943 apiece on the NSE.According to Jefferies,India’s CRDMO (Contract Research, Development, and Manufacturing Organization) industry is experiencing a major shift, evolving from traditional

990